gabapentin oral solution — CareFirst (Caremark)
Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients ≥ 3 years with epilepsy
Initial criteria
- Patient is not taking more than 3600 mg per day of gabapentin
Approval duration
12 months